VR Discharge Education After TURP

August 31, 2026 updated by: Hilal Hatice Ülkü, Aydin Adnan Menderes University

Effect of Virtual Reality-Assisted Discharge Education on Readiness for Hospital Discharge Following Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: A Randomized Controlled Trial

This randomized controlled trial evaluated the effect of virtual reality-assisted discharge education on readiness for hospital discharge among patients undergoing transurethral resection of the prostate (TURP) for benign prostatic hyperplasia (BPH). Patients were randomly assigned to either a virtual reality-based education group or a control group receiving standard discharge education. The intervention provided immersive and interactive learning experiences to enhance patients' understanding of post-discharge care. Readiness for hospital discharge was assessed using a validated scale. It is anticipated that patients receiving virtual reality-based education will demonstrate higher levels of readiness compared to those receiving standard education. The findings may support the integration of innovative educational technologies into postoperative patient education to improve discharge outcomes.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This randomized controlled trial aimed to evaluate the effect of virtual reality-based discharge education on patients' readiness for hospital discharge after TURP for benign prostatic hyperplasia. Patients were randomly assigned to either a virtual reality-based education group or a control group receiving standard discharge education. The intervention provided immersive and interactive learning experiences to enhance patients' understanding of post-discharge care. Readiness for hospital discharge was assessed using a validated scale. It is anticipated that patients receiving virtual reality-based education will demonstrate higher levels of readiness compared to those receiving standard education. The findings may support the integration of innovative educational technologies into postoperative patient education to improve discharge outcomes.

Study Type

Interventional

Enrollment (Actual)

68

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
    • Aydın
      • Efeler, Aydın, Turkey (Türkiye), 09090
        • Aydın Adnan Menderes University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Being able to speak and understand Turkish
  • Being literate
  • Being over 18 years of age

Exclusion Criteria:

  • Having a visual or hearing impairment
  • Having previously undergone TURP
  • Being a member of the healthcare staff

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental group (Discharge education)
In addition to routine discharge education, patients undergoing transurethral resection of the prostate (TURP) for benign prostatic hyperplasia received a virtual reality-assisted discharge education approximately two hours before surgery. The intervention was delivered individually in the urology clinic using an Oculus Quest 2 VR headset and consisted of a standardized 17-minute educational video covering postoperative self-care, including catheter care, bleeding management, pain management, nutrition, mobilization, medication use, warning signs requiring medical attention, and home care after discharge. Participants completed the Readiness for Hospital Discharge Scale-Short Form (RHDS-SF) before surgery (baseline) and again immediately before hospital discharge.
Other: Discharge Education

Intervention Group: Virtual Reality-Based Discharge Education

In addition to standard perioperative education, patients in the intervention group received a virtual reality-based educational intervention before surgery. This intervention was delivered in the urology clinic's procedure room using VR headsets and consisted of an approximately structured educational video covering postoperative care and discharge-related information. The aim was to provide an immersive and interactive learning experience to enhance patient understanding and preparedness. As in the control group, readiness for hospital discharge was assessed prior to discharge using the same validated instrument.
No Intervention: Control group (Placebo)
Patients allocated to the control group received routine discharge education approximately two hours before surgery, consistent with standard clinical practice. The education was delivered verbally by the ward nurse and included information on catheter care, medication use, and seeking medical attention in the event of postoperative bleeding. No additional educational intervention or VR-assisted education was provided. Participants completed the Readiness for Hospital Discharge Scale-Short Form (RHDS-SF) before surgery (baseline) and again immediately before hospital discharge. Following completion of outcome assessment, patients in the control group were offered access to the VR educational video for ethical reasons.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Readiness for Discharge Scale - Patient Self-Assessment Form
Time Frame: Before surgery (baseline)
This scale, which allows patients to assess their own readiness for discharge, consists of eight items and four subscales. Adapted into Turkish by Kaya and colleagues in 2017, this scale features questions parallel to those in the nursing version. The scale has a Cronbach's alpha value of 0.74 and employs a 10-point Likert-type rating scale.
Before surgery (baseline)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Readiness for Discharge Scale - Patient Self-Assessment Form
Time Frame: Second postoperative day, immediately before hospital discharge
This scale, which allows patients to assess their own readiness for discharge, consists of eight items and four subscales. Adapted into Turkish by Kaya and colleagues in 2017, this scale features questions parallel to those in the nursing version. The scale has a Cronbach's alpha value of 0.74 and employs a 10-point Likert-type rating scale.
Second postoperative day, immediately before hospital discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Aydin Adnan Menderes University

Investigators

  • Study Chair: HiLAL H ÜLKÜ, PhD, Aydin Adnan Menderes University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 15, 2024

Primary Completion (Actual)

November 15, 2024

Study Completion (Actual)

November 15, 2024

Study Registration Dates

First Submitted

March 24, 2026

First Submitted That Met QC Criteria

March 30, 2026

First Posted (Actual)

April 2, 2026

Study Record Updates

Last Update Posted (Actual)

September 2, 2026

Last Update Submitted That Met QC Criteria

August 31, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • VR Discharge Education

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The data sets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request

IPD Sharing Time Frame

6 months after publication

IPD Sharing Access Criteria

relevance to the topic of the study and approval of all co-authors within 1 month of receiving the request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe